Estudo da indústria farmacêutica brasileira: a queda das patentes e entrada dos medicamentos genéricos

The objective of this study is to examine the pharmaceutical industry and changes that the fall of patents and entry of generics may cause in the price and consumption of drugs. Thus, there is a brief discussion about the global pharmaceutical industry, from its origins to the present day, showing in particular the case of the United States, today considered the largest industry in this sector. From this, the work seeks to address specifically the Brazilian industry and its regulation. Since the generic law implementation, the participation of this type of medicine has grown significantly in the country. Because they have always been lower than prices of their brand, the cost of treating disease is reduced, which makes generic drugs represent an improvement for consumers in terms of welfare of society

A indústria farmacêutica no Brasil: um estudo do impacto socioeconômico dos medicamentos genéricos

Recently, some countries outside the Triad (Japan, Europe and the United States) have assumed an important role in the pharmaceutical scenario, as large producers, among them stand out Brazil. In the 90s, there were major institutional transformations and the pharmaceutical industry has undergone a reverse specialization process, because liberalization has discouraged production of pharmaceutical chemicals and dependence of imports increased. The law of generics medicines in 1999 emerged as an attempt to increase the population's access to medicines equivalent to ones with brand, with more affordable prices. As a result of this law there was a strengthening of the national capital and a major attraction for foreign companies to brazilian market. This study aims to assess the development trajectory of the country, showing how path-dependence has culminated in greater empowerment of national pharmaceutical industries after the Generics Law in 1999

Estratégias Produtivas e Tecnológicas das empresas da Indústria Farmacêutica do Brasil e da Índia: um exame a partir de indicadores aplicados aos fluxos de comércio exterior

This work aims to evaluate the different trajectories in terms of production structure, technological capabilities and performance in international trade of pharmaceutical industries in Brazil and India. For this, we build international trade indicators, based on data provided by the COMTRADE, the UN database for trade. Through the indicators, it is observed that the countries have different results in the catch-up process of the pharmaceutical industry. India has built a productive structure strongly based on generic drugs, with which it is able to greatly meet domestic demand and export to many countries worldwide. Brazil remains in a position of dependence of foreign production, with a high level of imports and exports to the region of Latin America

O desenvolvimento da indústria farmacêutica no Brasil e na Índia: um estudo comparativo

The article shows how the development of the pharmaceutical industry in Brazil and India occurred, and why the industry in these two countries, which until the 1970s were much alike, today show significant differences. The historical analysis of the trajectories of the industries in both countries showed that the Indian industry has a higher technological content, due to, among others, the efficiency of public policies implemented since the 1970s, which were aimed at improving not only production, but also the technological development.

Estratégias tecnológicas em transformação: um estudo da indústria farmacêutica brasileira

The aim of this research is to analyze the extension of changes in technological strategies of a group of Brazilian pharmaceutical companies, which we believe were induced by transformations in the institutional environment during the 1990s. Major institutional changes, such as the enacting of laws that recognized drug patents rights and fostered generic drugs market, have strengthened the market insertion and competitive position of these companies, what would enable an increase in research and development efforts in Brazil. In addition to the literature on technology strategy and drug industry, this study was based on interviews with six Brazilian pharmaceutical companies, all of which were ranked among the top national companies in the industry and have been considered in previous studies particularly active in the process of changing technological strategies. This research confirmed a significant intensification of technology efforts carried out by Brazilian drug companies. Nevertheless, the R&D intensity is still far below the global pattern and innovative impacts are slight.

Opiniões e atitudes dos médicos frente às ações promocionais da indústria farmacêutica

The pharmaceutical industry invests heavily in promoting their products, and studies suggest that these actions influence doctor’s prescribing. Therefore, this study aimed to analyze the opinions and attitudes of doctors when facing promotional activities of the laboratories. To this end, questionnaires were sent to doctors in Araraquara (SP) containing statements on the subject. Data analysis included study of the association by the chi-square. The results indicated that physicians relate to the propagandists (98%) by considering them useful (55%), but not as a main source update (86%). For 62% of them their prescriptions are not influenced by such relationships, while 24% disagree that doctors in general are influenced as well as new graduates (37%). The majority also disagrees that are influenced by amenities (86%) or free samples (70%) but only 38% believe their colleagues are not influenced by the samples. As for the ethics of these receipts, 57% considered to be appropriate when benefit patients, but only 32% while for personal use. The results show that doctors are vulnerable to the influences of marketing. Therefore, mechanisms and interventions are needed for prescribing drugs solely by criteria of effectiveness, safety, convenience and accessibility to the patient.

Os neurocosméticos e os desafios futuros para o farmacêutico e indústria farmacêutica

Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas Moniz

Desenvolvimento pré-clínico de novas moléculas terapêuticas: tendências na indústria farmacêutica

Dissertação para obtenção do grau de Mestre no Instituto Superior de Ciências da Saúde Egas Moniz

APRENDIZAGEM ORGANIZACIONAL EM SUAS DIFERENTES DIMENSÕES: A VISÃO DOS GERENTES DE UMA INDÚSTRIA FARMACÊUTICA

Esse estudo tem como propósito investigar como se desenvolve a aprendizagem organizacional (AO) e identificar como a aprendizagem individual e grupal contribui para este processo. A aprendizagem pode-se tornar uma vantagem competitiva, uma vez que a organização aprende mais rápido e busca aumentar a capacidade da empresa em ações de melhoria de desempenho. Enquanto parâmetros metodológicos adotou-se uma abordagem qualitativa de pesquisa, da qual participaram seis gestores de nível intermediário pertencentes a uma organização do ramo farmacêutico. O instrumento para coleta de dados configurou-se na entrevista baseada em roteiro semiestruturado. Os resultados evidenciaram que a aprendizagem organizacional se manifesta enquanto processo e como resultado, bem como sua importância para o desenvolvimento da vantagem competitiva na empresa, além de apontar também a relevância e a contribuição da aprendizagem individual e grupal para a AO.